Chronic Sleep Problems: A Symptom-First Treatment Guide

Written by: Matthew Timmins, Founder and Managing Director, Leva Sleep

Updated September 29, 2026

Key Takeaways

Chronic insomnia means difficulty falling or staying asleep at least three nights a week for three months or longer, with daytime consequences.
CBT-I (cognitive behavioral therapy for insomnia) is the first-line, most effective treatment and outperforms medication over the long term.
Medication sits in a third-line role and benefits fade after stopping, while CBT-I gains usually persist.
Underlying conditions such as sleep apnea, restless legs syndrome, and depression need treatment alongside insomnia.
Leva Sleep adjustable beds offer independent per-side positioning and head elevation that can support many chronic sleep treatment plans.

The Treatment Ladder Overview

CBT-I (cognitive behavioral therapy for insomnia) — first-line treatment
Behavioral strategies (stimulus control, sleep restriction, relaxation training)
Medication (prescription sleep aids, selected by symptom pattern and medical history)
Treating underlying conditions (sleep apnea, restless legs syndrome, circadian rhythm disorders, chronic pain, depression, anxiety)
The sleep environment (head elevation, independent per-side positioning)

What Makes Sleep Problems Chronic?

The National Heart, Lung, and Blood Institute (NHLBI) defines chronic insomnia as difficulty falling or staying asleep at least three nights a week for three months or longer. That threshold matters because treatment recommendations differ substantially for acute sleep problems, which last days to weeks, versus chronic ones. Someone who has slept badly for two weeks may only need better sleep hygiene. Once the problem has persisted for three months or more, on three or more nights per week, it meets the clinical definition of chronic insomnia disorder and calls for a different level of care.

The AASM's International Classification of Sleep Disorders (ICSD-3) additionally requires that the patient has an adequate opportunity to sleep. That criterion distinguishes chronic insomnia from sleep deprivation caused by insufficient time in bed. Daytime consequences such as impaired concentration, mood disturbance, and fatigue form a required part of the diagnosis.

Most Effective Treatment: CBT-I

CBT-I is the most effective treatment for chronic insomnia. The American Academy of Sleep Medicine's 2021 behavioral-psychological treatment guideline issued a strong recommendation for multicomponent CBT-I, the only strong recommendation in that document, with every other recommendation rated conditional. CBT-I involves five core components: sleep restriction, stimulus control, cognitive restructuring, relaxation training, and sleep hygiene education. A typical CBT-I program consists of 4–8 sessions over 6–12 weeks, with improvement typically beginning within two to four weeks and significant improvement by six to eight weeks.

CBT-I performs as well as or better than medication for chronic insomnia, and its gains usually hold after treatment ends. A 2015 meta-analysis in Annals of Internal Medicine covering 20 randomized trials found that CBT-I cut time to fall asleep by about 19 minutes and time awake during the night by about 26 minutes. It also raised sleep efficiency by roughly 10 percentage points, with no adverse outcomes reported in any trial.

The AASM's 2026 clinical practice guideline, published April 13, 2026, in the Journal of Clinical Sleep Medicine, issued a conditional recommendation that CBT-I combined with medication may be appropriate over medication alone in some circumstances. The same guideline issued a conditional recommendation against combination treatment over CBT-I alone. This hierarchy places CBT-I first, combination therapy second, and medication alone third. The 2026 guidance notes that patients who place higher value on increasing total sleep time early in treatment may reasonably choose combination treatment, and that choice remains a case-dependent clinical decision.

The first couple of weeks of CBT-I are usually the hardest. Sleep restriction, often the most powerful CBT-I component, can make sleep worse before it gets better, with improvement typically beginning within two to four weeks. That early worsening is how sleep restriction works.

Accessing CBT-I in the United States

Access to CBT-I is the single largest gap between guideline recommendations and real-world care. A geographic survey counted 659 behavioral sleep medicine providers in the United States, with 105 of the 167 U.S. cities over 150,000 people having none at all and four states having none. Most patients with chronic insomnia have never been offered CBT-I and instead receive prescriptions.

There are three practical routes to CBT-I in the United States:

A trained therapist (in person or telehealth). When a licensed clinician delivers CBT-I, it is typically billed as behavioral health and goes through the same insurance benefits as any therapy visit. A randomized noninferiority trial found that patients treated for insomnia over video did not do worse than those treated in the office, so telehealth is a clinically equivalent option where in-person providers are scarce. Access and cost vary by market and insurance plan, so benefits should be verified before starting.
A digital CBT-I program. Several validated digital programs deliver the same components as therapist-guided CBT-I and are a reasonable first step when in-person care is not available. Two programs, Somryst and SleepioRx, are FDA-cleared and categorized as evidence-based, reimbursable digital mental health treatments by the Centers for Medicare and Medicaid Services (CMS), though not all insurance carriers cover digital programs. Patients who have more human support tend to do better, so a fully self-guided app works best as a starting point.
A referral through a primary care doctor or sleep clinic. A primary care physician can refer to a sleep specialist or behavioral sleep medicine provider, and some sleep clinics offer CBT-I directly. The AASM's 2026 guideline recommends that clinicians facilitate access to CBT-I by using as many in-person, telehealth, and digital resources as possible.

A 2026 review in Current Sleep Medicine Reports notes an average lag of approximately 17 years for evidence-based practices to achieve widespread clinical adoption. That lag helps explain why CBT-I, first-line since at least 2016, still remains harder to access than a prescription.

Medication Options and Trade-Offs

Medication sits third on the treatment ladder. When clinicians use it, the choice depends on the specific sleep problem, such as trouble falling asleep versus staying asleep, as well as medical history and other medications. The major classes and agents currently in use include:

Low-dose antidepressant: Doxepin, conditionally recommended by the AASM for sleep maintenance insomnia.
Melatonin receptor agonist: Ramelteon, conditionally recommended for sleep onset insomnia.
Non-benzodiazepine hypnotics (Z-drugs): Zolpidem, zaleplon, eszopiclone, which carry risks including sleep-related complex behaviors, tolerance, dependence, memory effects, and increased fall risk, and were initially marketed as safer than benzodiazepines despite accumulating evidence of similar concerns.
Orexin receptor antagonists: Suvorexant, lemborexant, daridorexant, with strongest evidence for sleep-maintenance benefits and a less concerning side effect profile than Z-drugs, though still recommended as adjunctive rather than first-line.

The most common misinformation concerns melatonin. The VA/DoD chronic insomnia guideline recommends against melatonin for chronic insomnia, with evidence rated very low. Melatonin is useful for circadian rhythm disorders and jet lag but has only a modest effect for primary insomnia; long-term safety data are limited, and product quality varies because it is a supplement rather than a regulated medication. Melatonin use for chronic insomnia does not match the effect of a full treatment plan.

The trade-offs real sufferers raise, such as next-day grogginess, dependence concerns, and the sense that the medication stops working, are real and documented. Medication gains do not hold after discontinuation. That pattern marks a key difference between pharmacotherapy and CBT-I.

Underlying Conditions That Disrupt Sleep

Treating underlying conditions runs alongside every other layer of the treatment ladder. The most common contributors include:

Sleep apnea. Positive airway pressure (PAP) therapy, including CPAP, APAP, and BiPAP, is the most common and effective initial treatment for obstructive sleep apnea. Oral appliances are custom-fitted mouthpieces most often used for mild sleep apnea. Positional therapy, such as sleeping on the side or with the head elevated, forms part of lifestyle management. For more on adjustable beds and sleep apnea, see Sleep Apnea Adjustable Beds: What Helps and How To Choose.
Restless legs syndrome (RLS). Up to 15% of people have RLS, which causes limb discomfort and a powerful urge to move when lying down; iron deficiency and certain medications can worsen symptoms. Most people with RLS also have insomnia symptoms because the condition makes it hard to fall asleep.
Circadian rhythm disorders. Circadian rhythm disorders affect the timing of sleep, with examples including delayed sleep phase disorder and shift work disorder. Treatment typically involves timed light exposure, melatonin at specific times, and behavioral schedule adjustment.
Chronic pain. Pain disrupts sleep architecture directly and perpetuates insomnia independently of the pain's cause. CBT-I has been shown to work alongside chronic pain rather than requiring the pain to resolve first.
Depression and anxiety. Sleep apnea and depression have a bidirectional relationship, and about 23% of people with obstructive sleep apnea also have clinical depression. When insomnia is secondary to another condition, treating the underlying condition is an important part of care, yet insomnia often persists independently, and treating it directly can improve the co-occurring condition.
Medication side effects. Certain antidepressants, corticosteroids, stimulants, and other medications disrupt sleep as a side effect. A medication review with the prescribing physician is warranted when sleep problems coincide with a new prescription.

Treatment Options for Fragmented Sleep

Symptom pattern matters. The treatments typically considered differ depending on which part of the night is the problem:

Trouble falling asleep: CBT-I, particularly stimulus control and sleep restriction, plus options such as ramelteon or zaleplon.
Waking in the night: CBT-I, particularly sleep restriction, doxepin, suvorexant, and evaluation for underlying conditions including sleep apnea and pain.
Waking too early: CBT-I, particularly cognitive restructuring, along with evaluation and treatment of depression or anxiety and circadian rhythm assessment.
Daytime sleepiness despite adequate time in bed: Sleep study referral to rule out sleep apnea, CPAP or oral appliance if apnea is confirmed, and a medication review for sedating agents that impair daytime alertness.

Bringing the specific symptom pattern to a primary care physician or sleep specialist allows the treatment plan to match the actual problem rather than insomnia as a generic category.

The Sleep Environment as Part of the Treatment Plan

The sleep environment can support or undermine every other part of a treatment plan. Clinicians commonly recommend sleeping with the head elevated for conditions including sleep apnea, acid reflux, and post-surgical recovery. An adjustable base achieves that position at home, night after night, without stacking pillows. Elevating the head gently opens the airway, which is why anti-snore positioning reduces snoring for many sleepers.

Partner disruption, such as one person’s snoring, movement, or frequent repositioning, undermines adherence to any treatment plan. In a 2025 survey of 2,007 US adults conducted by Atomik Research for the American Academy of Sleep Medicine, 31% of American adults said they had opted for a "sleep divorce"—regularly sleeping in a separate room from their partner; among adults aged 35–44, the figure rises to 39%. Independent per-side positioning addresses the underlying problem while allowing partners to stay in the same room.

Leva Sleep is a specialist adjustable bed company. Its complete sleep systems offer independent per-side articulation, lumbar control, pillow tilt, and anti-snore positioning, and the mattresses are engineered to flex with the base. The bedding is designed for movement. As a Leva Sleep specialist puts it: "You can’t solve a geometry problem by changing the foam. That’s the mistake almost every mattress purchase makes." [Quote attributed to Leva Sleep specialist — name and title to be assigned.]

Leva Sleep offers the largest selection of Split Queen adjustable beds in North America, with five packages from $1,399, 30″ × 80″ mattresses Leva manufactures itself, and a full Split Queen accessory line. The typical retailer offers none. For couples managing snoring or airway positioning, the snoring relief collection and the pain relief collection address the two most common reasons a clinician recommends an elevated sleeping position. For more on how adjustable positioning works alongside snoring management, see Adjustable Bed for Snoring: A Sourced Decision Guide.

*Heavenly Response Split Queen Adjustable Bed*

Comparison Table: Treatment Categories at a Glance

The table below summarizes the five layers of the treatment ladder side by side so you can compare timelines and trade-offs before choosing a starting point.

Treatment	What It Involves	Typical Timeline	Main Trade-Off
CBT-I	Stimulus control, sleep restriction, relaxation training, cognitive restructuring with a trained provider	6–8 weeks; improvement typically begins within 2–4 weeks	Requires active participation, and initial sleep restriction can worsen sleep before it improves
Behavioral strategies	Stimulus control, sleep restriction, relaxation training (may be delivered as single components per AASM 2021 guideline)	4–8 weeks	Less effective as single components than full multicomponent CBT-I and requires consistency
Medication classes	Doxepin, ramelteon, zolpidem, zaleplon, eszopiclone, suvorexant, selected by symptom pattern and medical history per AASM 2017 and 2026 guidelines	Varies; often short-term	Side effects, next-day grogginess, dependence concerns, and gains that do not hold after discontinuation
Treating underlying conditions	CPAP, oral appliances, positional therapy for sleep apnea; RLS treatment; circadian rhythm management	Varies by condition	Requires accurate diagnosis, and treatment adherence can be challenging
Sleep environment adjustments	Head elevation, independent per-side positioning, anti-snore positioning, and pressure relief via an adjustable base and matched mattress	Immediate to weeks	Requires an adjustable base and matched mattress and works as a support, not a standalone treatment for chronic insomnia

Frequently Asked Questions

Is CBT-I Covered by Insurance?

When delivered by a licensed clinician, CBT-I is typically billed as behavioral health and goes through the same insurance benefits as any therapy visit, including copays, deductibles, and in-network rules. App-only programs with no clinician involvement are a different case and frequently are not covered by insurance carriers. Patients should verify their specific benefits before starting any program. The AASM's 2026 combination-treatment guideline identifies insurance coverage as one of the structural barriers that must be resolved to improve equitable access to CBT-I.

How Long Does CBT-I Take to Work?

As noted earlier, CBT-I typically runs 4–8 sessions over 6–12 weeks, with improvement beginning within 2–4 weeks. The first one to two weeks can feel harder because sleep restriction often produces more daytime sleepiness before it produces better sleep. That pattern reflects the treatment mechanism rather than treatment failure. The AASM's 2021 guideline states that CBT-I typically produces gradual improvement rather than immediate results, with treatment ranging from 4–8 visits, whereas Zimmer Medical Group's May 2026 review states that improvement typically begins within 2–4 weeks, so the two sources describe the CBT-I timeline differently.

Can I Do CBT-I Without a Therapist?

Digital CBT-I programs deliver the same core components as therapist-guided CBT-I, including sleep restriction, stimulus control, cognitive restructuring, and relaxation training, and they are a reasonable first step when in-person care is not available. The AASM's 2026 guideline supports digital CBT-I as a legitimate access pathway. Patients who have more human support tend to do better because a clinician can adjust the protocol when the standard approach does not fit, catch untreated sleep apnea that is stalling progress, and support adherence through the harder early weeks. Self-guided programs work best as a starting point rather than a ceiling.

Is Melatonin Effective for Chronic Insomnia?

Melatonin has not been established as effective for chronic insomnia. The VA/DoD chronic insomnia guideline recommends against melatonin for chronic insomnia, with the evidence rated very low. Melatonin is useful for circadian rhythm disorders such as delayed sleep phase, jet lag, and shift work, where the problem is the timing of sleep rather than its quality or continuity. For primary chronic insomnia, it has only a modest effect. Product quality also varies considerably because melatonin is sold as a supplement rather than a regulated medication.

When Should I See a Sleep Specialist Instead of My Primary Care Doctor?

A sleep specialist referral is appropriate when CBT-I has been tried and has not produced adequate improvement, when sleep apnea is suspected, when restless legs syndrome or a circadian rhythm disorder is present, or when medication is being considered. Suspicion for sleep apnea rises with loud snoring, gasping, witnessed apneas, or excessive daytime sleepiness despite adequate time in bed. The AASM's Sleep Education diagnosis algorithm identifies clinical thresholds for sleep specialist referral, including obesity (BMI > 35), congestive heart failure, atrial fibrillation, treatment-refractory hypertension, type 2 diabetes, nocturnal dysrhythmia, stroke, pulmonary hypertension, and high-risk driving populations. A primary care physician is the right starting point for most people, and a sleep specialist is the right next step when the primary care pathway has been exhausted.

Do Adjustable Beds Help With Sleep Apnea and Reflux?

Clinicians commonly recommend sleeping with the head elevated for conditions including sleep apnea, acid reflux, and post-surgical recovery. An adjustable base achieves that position at home, night after night, without stacking pillows, which shift during the night and do not maintain a consistent angle. Elevating the head gently opens the airway, which is why anti-snore positioning reduces snoring for many sleepers. An adjustable base does not replace primary treatment for sleep apnea, and CPAP or an oral appliance remains the clinical standard for diagnosed OSA. The adjustable base addresses the positional component of the treatment plan and works alongside primary treatment.

Explore Leva Sleep Adjustable Beds for Head Elevation and Per-Side Positioning

Conclusion and Next Steps

Chronic sleep problems have a defined threshold and a clear treatment order. CBT-I is first-line. Behavioral strategies follow. Medication comes third and is selected by symptom pattern and medical history. Underlying conditions such as sleep apnea, restless legs syndrome, circadian rhythm disorders, depression, anxiety, and chronic pain are treated alongside all of these layers. The sleep environment, specifically head elevation and independent per-side positioning, supports every other part of the plan and often receives the least attention.

The most useful next step is to bring your symptom pattern, such as trouble falling asleep, waking in the night, waking too early, or daytime sleepiness despite time in bed, to a primary care physician or sleep specialist. Evaluating the sleep environment as part of that plan, rather than as an afterthought, creates a more complete approach.

Find a Leva Sleep Adjustable Bed That Fits Your Treatment Plan

Chronic Sleep Problems Treatment Options: A Decision Guide